RxDoctor Payments Data

Vicki Turnage

Family Medicine · Water Valley, MSNPI 1457419707

Payments from drug & device makers

$1,093in general payments, 2019–2025

Across 62 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$245
  • Abbott$148
  • Amarin Pharma, Inc.$125
  • Novo Nordisk$102
  • Boehringer Ingelheim$84
  • Bayer$67
  • plus $321 from 9 others

What the payments were for

  • Food & beverage$1,093100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,093 in reported general payments places this provider in the 60th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$3,482
Medicare patients
67
Services billed
158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide89$117,495
LinzessLinaclotide100$70,082
JardianceEmpagliflozin67$69,059
EliquisApixaban64$62,947
MounjaroTirzepatide56$57,146
JanuviaSitagliptin Phosphate46$49,548
RybelsusSemaglutide22$36,703
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$27,033
EntrestoSacubitril/Valsartan14$20,313
FarxigaDapagliflozin Propanediol29$19,640
TrulicityDulaglutide22$19,600
Tresiba Flextouch U-200Insulin Degludec24$18,853
Breo ElliptaFluticasone/Vilanterol24$12,680
MyrbetriqMirabegron25$11,994
TradjentaLinagliptin13$10,679

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Novolog$102$156,159125 claims
Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr$84$83,32791 claims
Lilly USA, LLCMounjaro, Trulicity$50$76,74678 claims
AbbVieLinzess, Synthroid$245$71,556120 claims
PfizerEliquis$35$62,94764 claims
GSKTrelegy Ellipta, Breo Ellipta$33$39,71357 claims
AstraZenecaFarxiga, Symbicort$58$23,86944 claims
Astellas Pharma US IncMyrbetriq$36$11,99425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Water Valley

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →